Proof of Usefulness Report

Iterative Health

Analysis completed on 1/24/2026

+622
Proof of Usefulness Score
Category Standard

Iterative Health is a verified, high-value Series B healthcare technology company with over $195M in funding and FDA-cleared AI solutions (e.g., SKOUT) for gastroenterology. However, the project submission itself is of extremely low quality, containing demonstrably false claims (e.g., 'most people have used my product', 'audience reach: everyone') and lazy data entry. The score reflects the company's significant real-world utility, innovation, and verified external traction (partnerships with Eli Lilly, Gastro Health), but is heavily penalized by low Quality Factors due to the submission's failure to provide accurate evidence.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+237.5
Audience Reach Impact+85.0
Technical Innovation+135.0
Evidence Of Traction+118.8
Market Timing Relevance+95.0
Functional Completeness+5.0
Subtotal+676.3
Usefulness Multiplierx0.92
Final Score+622

Project Details

Project URL
iterative.health
Description
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases.\n\nIterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline